Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Loss of Cutibacterium is responsible for chronic kidney disease-associated pruritus in patients on dialysis: Jeong Geon Lee, Hoonhee Seo, Seung Seob Son et al.; Received March 9, 2023 Accepted May 4, 2023 Published online September 6, 2023; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Review Articles

The impact of hypoxia-inducible factors in the pathogenesis of kidney diseases: a link through cell metabolism: Orestes Foresto-Neto, Ana Ruth Paolinetti Alves da Silva, Marcella Cipelli, Fernanda Paula Roncon Santana-Novelli, Niels Olsen Saraiva Camara; Kidney Res Clin Pract. 2023;42(5):561-578. Published online June 15, 2023; DOI: https://doi.org/10.23876/j.krcp.23.012
Web of Science 1 Cited By 1; Full text PubReader ePub PDF

Intestinal microbiota and kidney diseases: Myung-Gyu Kim, Jihyun Yang, Sang-Kyung Jo; Kidney Res Clin Pract. 2021;40(3):335-343. Published online June 9, 2021; DOI: https://doi.org/10.23876/j.krcp.21.053
Web of Science 19 Cited By 21; Full text PubReader ePub PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,573	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,515	C4d Puzzle in ABO-incompatible kidney transplantation
7,923	How should we treat acute kidney injury caused by renal congestion?
12,737	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,815	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.